Law360, New York (July 24, 2006, 12:00 AM EDT) -- Amid criticism of conflicts of interest in its advisory committee processes, the Food and Drug Administration said Monday it plans to develop guidelines to ensure that outside experts who provide scientific advice to the agency do not have ties to industries under the FDA’s regulation.
Although the FDA is not required to implement the recommendations of outside advisors, advisory committees play an important role in informing the agency on complex scientific issues involving drugs and other regulated products, with the FDA typically following such guidance....
FDA Bolsters Rules On Outside Advisors
To view the full article, register now.
Try Law360 FREE for seven days
Already a subscriber? Click here to login
